nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—Cyclizine—Benzphetamine—obesity	0.0632	1	CrCrCtD
Loxapine—DRD4—obesity	0.0524	0.169	CbGaD
Loxapine—HTR1B—obesity	0.0466	0.151	CbGaD
Loxapine—DRD1—obesity	0.0444	0.143	CbGaD
Loxapine—ADRB1—obesity	0.0412	0.133	CbGaD
Loxapine—HTR2C—obesity	0.0379	0.123	CbGaD
Loxapine—SLC6A4—obesity	0.0314	0.102	CbGaD
Loxapine—DRD2—obesity	0.0313	0.101	CbGaD
Loxapine—SLC6A3—Diethylpropion—obesity	0.0263	0.0624	CbGbCtD
Loxapine—HTR2A—obesity	0.0242	0.0781	CbGaD
Loxapine—HRH2—Cimetidine—obesity	0.0201	0.0479	CbGbCtD
Loxapine—SLC6A3—Phendimetrazine—obesity	0.0199	0.0473	CbGbCtD
Loxapine—SLC6A3—Sibutramine—obesity	0.0199	0.0473	CbGbCtD
Loxapine—SLC6A2—Diethylpropion—obesity	0.0192	0.0457	CbGbCtD
Loxapine—SLC6A4—Sibutramine—obesity	0.0174	0.0414	CbGbCtD
Loxapine—ADRA1B—Phendimetrazine—obesity	0.016	0.0379	CbGbCtD
Loxapine—SLC6A3—Phentermine—obesity	0.0151	0.0358	CbGbCtD
Loxapine—SLC6A3—Benzphetamine—obesity	0.0151	0.0358	CbGbCtD
Loxapine—SLC6A2—Phendimetrazine—obesity	0.0146	0.0346	CbGbCtD
Loxapine—SLC6A2—Sibutramine—obesity	0.0146	0.0346	CbGbCtD
Loxapine—SLC6A3—Phenylpropanolamine—obesity	0.0144	0.0342	CbGbCtD
Loxapine—DRD1—Phenylpropanolamine—obesity	0.0144	0.0342	CbGbCtD
Loxapine—SLC6A4—Phentermine—obesity	0.0132	0.0314	CbGbCtD
Loxapine—SLC6A3—Bupropion—obesity	0.0128	0.0305	CbGbCtD
Loxapine—ADRA1A—Phendimetrazine—obesity	0.0126	0.0299	CbGbCtD
Loxapine—ADRB1—Phenylpropanolamine—obesity	0.0124	0.0295	CbGbCtD
Loxapine—SLC6A3—Methamphetamine—obesity	0.0121	0.0286	CbGbCtD
Loxapine—ADRA2C—Methamphetamine—obesity	0.0121	0.0286	CbGbCtD
Loxapine—ADRA2B—Methamphetamine—obesity	0.0114	0.0272	CbGbCtD
Loxapine—SLC6A2—Phentermine—obesity	0.011	0.0262	CbGbCtD
Loxapine—SLC6A2—Benzphetamine—obesity	0.011	0.0262	CbGbCtD
Loxapine—SLC6A4—Methamphetamine—obesity	0.0105	0.0251	CbGbCtD
Loxapine—SLC6A2—Phenylpropanolamine—obesity	0.0105	0.025	CbGbCtD
Loxapine—ADRA2A—Benzphetamine—obesity	0.00995	0.0236	CbGbCtD
Loxapine—ADRA1A—Benzphetamine—obesity	0.00954	0.0227	CbGbCtD
Loxapine—ADRA2A—Phenylpropanolamine—obesity	0.00949	0.0226	CbGbCtD
Loxapine—SLC6A2—Bupropion—obesity	0.00938	0.0223	CbGbCtD
Loxapine—ADRA1A—Phenylpropanolamine—obesity	0.0091	0.0216	CbGbCtD
Loxapine—SLC6A2—Methamphetamine—obesity	0.00882	0.021	CbGbCtD
Loxapine—ADRA2A—Methamphetamine—obesity	0.00795	0.0189	CbGbCtD
Loxapine—HTR3A—area postrema—obesity	0.00599	0.188	CbGeAlD
Loxapine—HTR3A—vagus nerve—obesity	0.002	0.0628	CbGeAlD
Loxapine—CHRM3—muscle of abdomen—obesity	0.0017	0.0535	CbGeAlD
Loxapine—SLC6A2—sympathetic nervous system—obesity	0.00138	0.0435	CbGeAlD
Loxapine—HTR7—sympathetic nervous system—obesity	0.00133	0.0419	CbGeAlD
Loxapine—HTR7—vagus nerve—obesity	0.00129	0.0406	CbGeAlD
Loxapine—SLC6A2—autonomic nervous system—obesity	0.00093	0.0293	CbGeAlD
Loxapine—HTR7—autonomic nervous system—obesity	0.000896	0.0282	CbGeAlD
Loxapine—HTR2A—sympathetic nervous system—obesity	0.000831	0.0262	CbGeAlD
Loxapine—HTR2A—vagus nerve—obesity	0.000805	0.0253	CbGeAlD
Loxapine—HTR2A—autonomic nervous system—obesity	0.000559	0.0176	CbGeAlD
Loxapine—SLC6A3—hindbrain—obesity	0.000486	0.0153	CbGeAlD
Loxapine—SLC6A4—hindbrain—obesity	0.000445	0.014	CbGeAlD
Loxapine—HTR1A—hindbrain—obesity	0.000395	0.0124	CbGeAlD
Loxapine—HTR7—hindbrain—obesity	0.000378	0.0119	CbGeAlD
Loxapine—HTR3A—islet of Langerhans—obesity	0.000377	0.0119	CbGeAlD
Loxapine—ADRA1A—hindbrain—obesity	0.000364	0.0115	CbGeAlD
Loxapine—DRD2—hindbrain—obesity	0.000357	0.0112	CbGeAlD
Loxapine—HTR3A—respiratory system—obesity	0.000356	0.0112	CbGeAlD
Loxapine—HRH2—cardiovascular system—obesity	0.000347	0.0109	CbGeAlD
Loxapine—SLC6A3—respiratory system—obesity	0.000297	0.00933	CbGeAlD
Loxapine—HRH2—digestive system—obesity	0.000288	0.00907	CbGeAlD
Loxapine—HRH2—adrenal gland—obesity	0.000275	0.00864	CbGeAlD
Loxapine—SLC6A4—respiratory system—obesity	0.000272	0.00855	CbGeAlD
Loxapine—DRD5—endocrine gland—obesity	0.000254	0.00798	CbGeAlD
Loxapine—SLC6A2—respiratory system—obesity	0.000239	0.00753	CbGeAlD
Loxapine—HRH2—endocrine gland—obesity	0.000238	0.0075	CbGeAlD
Loxapine—HTR2A—hindbrain—obesity	0.000235	0.00741	CbGeAlD
Loxapine—Dizziness—Methamphetamine—obesity	0.000234	0.00315	CcSEcCtD
Loxapine—Cerebrovascular accident—Sibutramine—obesity	0.000233	0.00314	CcSEcCtD
Loxapine—Glaucoma—Topiramate—obesity	0.000232	0.00313	CcSEcCtD
Loxapine—HTR7—respiratory system—obesity	0.000231	0.00725	CbGeAlD
Loxapine—Leukopenia—Cimetidine—obesity	0.00023	0.0031	CcSEcCtD
Loxapine—Chest pain—Diethylpropion—obesity	0.00023	0.0031	CcSEcCtD
Loxapine—Insomnia—Phentermine—obesity	0.00023	0.00309	CcSEcCtD
Loxapine—HTR1B—cardiovascular system—obesity	0.000229	0.0072	CbGeAlD
Loxapine—CHRM2—cardiovascular system—obesity	0.000228	0.00717	CbGeAlD
Loxapine—Constipation—Phenylpropanolamine—obesity	0.000227	0.00305	CcSEcCtD
Loxapine—Photosensitivity—Bupropion—obesity	0.000227	0.00305	CcSEcCtD
Loxapine—HTR3A—digestive system—obesity	0.000227	0.00713	CbGeAlD
Loxapine—Dizziness—Benzphetamine—obesity	0.000225	0.00303	CcSEcCtD
Loxapine—Dry mouth—Diethylpropion—obesity	0.000225	0.00303	CcSEcCtD
Loxapine—Psychotic disorder—Sibutramine—obesity	0.000223	0.003	CcSEcCtD
Loxapine—HTR1D—cardiovascular system—obesity	0.000222	0.00698	CbGeAlD
Loxapine—Headache—Methamphetamine—obesity	0.000221	0.00298	CcSEcCtD
Loxapine—Gastrointestinal disorder—Phentermine—obesity	0.000219	0.00295	CcSEcCtD
Loxapine—Fatigue—Phentermine—obesity	0.000219	0.00295	CcSEcCtD
Loxapine—Nasal congestion—Bupropion—obesity	0.000219	0.00294	CcSEcCtD
Loxapine—Feeling abnormal—Phenylpropanolamine—obesity	0.000219	0.00294	CcSEcCtD
Loxapine—DRD2—respiratory system—obesity	0.000218	0.00686	CbGeAlD
Loxapine—Urinary retention—Sibutramine—obesity	0.000217	0.00292	CcSEcCtD
Loxapine—Constipation—Phentermine—obesity	0.000217	0.00292	CcSEcCtD
Loxapine—Tachycardia—Diethylpropion—obesity	0.000216	0.0029	CcSEcCtD
Loxapine—ADRB1—cardiovascular system—obesity	0.000215	0.00678	CbGeAlD
Loxapine—HRH2—liver—obesity	0.000215	0.00676	CbGeAlD
Loxapine—Headache—Benzphetamine—obesity	0.000213	0.00287	CcSEcCtD
Loxapine—Confusional state—Cimetidine—obesity	0.000212	0.00285	CcSEcCtD
Loxapine—Orthostatic hypotension—Sibutramine—obesity	0.000209	0.00281	CcSEcCtD
Loxapine—CHRM1—cardiovascular system—obesity	0.000207	0.00652	CbGeAlD
Loxapine—Thrombocytopenia—Cimetidine—obesity	0.000206	0.00277	CcSEcCtD
Loxapine—Dizziness—Phendimetrazine—obesity	0.000205	0.00276	CcSEcCtD
Loxapine—Tachycardia—Cimetidine—obesity	0.000205	0.00276	CcSEcCtD
Loxapine—Cerebrovascular accident—Bupropion—obesity	0.000203	0.00274	CcSEcCtD
Loxapine—Nausea—Benzphetamine—obesity	0.000202	0.00272	CcSEcCtD
Loxapine—Sensory loss—Topiramate—obesity	0.000202	0.00272	CcSEcCtD
Loxapine—Bronchospasm—Orlistat—obesity	0.000201	0.0027	CcSEcCtD
Loxapine—Insomnia—Diethylpropion—obesity	0.0002	0.00269	CcSEcCtD
Loxapine—Amenorrhoea—Topiramate—obesity	0.000199	0.00268	CcSEcCtD
Loxapine—Dysphagia—Sibutramine—obesity	0.000197	0.00266	CcSEcCtD
Loxapine—Dyspnoea—Diethylpropion—obesity	0.000197	0.00265	CcSEcCtD
Loxapine—Somnolence—Diethylpropion—obesity	0.000196	0.00264	CcSEcCtD
Loxapine—Hypersensitivity—Phenylpropanolamine—obesity	0.000195	0.00263	CcSEcCtD
Loxapine—Headache—Phendimetrazine—obesity	0.000195	0.00262	CcSEcCtD
Loxapine—Psychotic disorder—Bupropion—obesity	0.000195	0.00262	CcSEcCtD
Loxapine—Gastrointestinal disorder—Diethylpropion—obesity	0.000191	0.00257	CcSEcCtD
Loxapine—ADRB1—adipose tissue—obesity	0.00019	0.00598	CbGeAlD
Loxapine—Urinary retention—Bupropion—obesity	0.000189	0.00255	CcSEcCtD
Loxapine—Constipation—Diethylpropion—obesity	0.000189	0.00254	CcSEcCtD
Loxapine—Somnolence—Cimetidine—obesity	0.000187	0.00252	CcSEcCtD
Loxapine—Dyskinesia—Topiramate—obesity	0.000186	0.0025	CcSEcCtD
Loxapine—Dysarthria—Topiramate—obesity	0.000185	0.00249	CcSEcCtD
Loxapine—HTR1A—cardiovascular system—obesity	0.000185	0.00581	CbGeAlD
Loxapine—Nausea—Phendimetrazine—obesity	0.000184	0.00248	CcSEcCtD
Loxapine—Asthenia—Phentermine—obesity	0.000182	0.00245	CcSEcCtD
Loxapine—Feeling abnormal—Diethylpropion—obesity	0.000182	0.00245	CcSEcCtD
Loxapine—Orthostatic hypotension—Bupropion—obesity	0.000182	0.00245	CcSEcCtD
Loxapine—Fatigue—Cimetidine—obesity	0.000181	0.00244	CcSEcCtD
Loxapine—Photosensitivity reaction—Sibutramine—obesity	0.00018	0.00243	CcSEcCtD
Loxapine—Constipation—Cimetidine—obesity	0.00018	0.00242	CcSEcCtD
Loxapine—Weight increased—Sibutramine—obesity	0.00018	0.00242	CcSEcCtD
Loxapine—ADRA2A—islet of Langerhans—obesity	0.000179	0.00563	CbGeAlD
Loxapine—Gait disturbance—Topiramate—obesity	0.000179	0.00241	CcSEcCtD
Loxapine—Renal failure—Orlistat—obesity	0.000179	0.00241	CcSEcCtD
Loxapine—Muscle twitching—Topiramate—obesity	0.000178	0.0024	CcSEcCtD
Loxapine—ADRA2C—adrenal cortex—obesity	0.000178	0.0056	CbGeAlD
Loxapine—HTR7—cardiovascular system—obesity	0.000177	0.00556	CbGeAlD
Loxapine—Dizziness—Phenylpropanolamine—obesity	0.000175	0.00236	CcSEcCtD
Loxapine—Feeling abnormal—Cimetidine—obesity	0.000173	0.00233	CcSEcCtD
Loxapine—Renal failure—Sibutramine—obesity	0.000173	0.00233	CcSEcCtD
Loxapine—SLC6A4—digestive system—obesity	0.000173	0.00544	CbGeAlD
Loxapine—HRH1—respiratory system—obesity	0.000172	0.00542	CbGeAlD
Loxapine—Dysphagia—Bupropion—obesity	0.000172	0.00232	CcSEcCtD
Loxapine—ADRA1A—cardiovascular system—obesity	0.00017	0.00536	CbGeAlD
Loxapine—Salivary hypersecretion—Topiramate—obesity	0.00017	0.00229	CcSEcCtD
Loxapine—Bronchospasm—Bupropion—obesity	0.000169	0.00228	CcSEcCtD
Loxapine—Vomiting—Phenylpropanolamine—obesity	0.000169	0.00227	CcSEcCtD
Loxapine—Dizziness—Phentermine—obesity	0.000168	0.00226	CcSEcCtD
Loxapine—Rash—Phenylpropanolamine—obesity	0.000167	0.00225	CcSEcCtD
Loxapine—Dermatitis—Phenylpropanolamine—obesity	0.000167	0.00225	CcSEcCtD
Loxapine—CHRM3—adipose tissue—obesity	0.000164	0.00515	CbGeAlD
Loxapine—Hepatitis—Orlistat—obesity	0.000163	0.0022	CcSEcCtD
Loxapine—Dry eye—Topiramate—obesity	0.000161	0.00217	CcSEcCtD
Loxapine—Vomiting—Phentermine—obesity	0.000161	0.00217	CcSEcCtD
Loxapine—Rash—Phentermine—obesity	0.00016	0.00215	CcSEcCtD
Loxapine—Dermatitis—Phentermine—obesity	0.00016	0.00215	CcSEcCtD
Loxapine—Headache—Phentermine—obesity	0.000159	0.00214	CcSEcCtD
Loxapine—Nausea—Phenylpropanolamine—obesity	0.000158	0.00212	CcSEcCtD
Loxapine—Hypoaesthesia—Sibutramine—obesity	0.000157	0.00212	CcSEcCtD
Loxapine—Photosensitivity reaction—Bupropion—obesity	0.000157	0.00212	CcSEcCtD
Loxapine—HTR1B—endocrine gland—obesity	0.000157	0.00494	CbGeAlD
Loxapine—Weight increased—Bupropion—obesity	0.000157	0.00211	CcSEcCtD
Loxapine—CHRM2—endocrine gland—obesity	0.000156	0.00492	CbGeAlD
Loxapine—Weight decreased—Bupropion—obesity	0.000156	0.0021	CcSEcCtD
Loxapine—Hypersensitivity—Cimetidine—obesity	0.000155	0.00208	CcSEcCtD
Loxapine—CHRM3—digestive system—obesity	0.000154	0.00485	CbGeAlD
Loxapine—Nausea—Phentermine—obesity	0.000151	0.00203	CcSEcCtD
Loxapine—Asthenia—Cimetidine—obesity	0.000151	0.00203	CcSEcCtD
Loxapine—ADRA1A—adipose tissue—obesity	0.00015	0.00473	CbGeAlD
Loxapine—Jaundice—Bupropion—obesity	0.00015	0.00201	CcSEcCtD
Loxapine—Azelastine—HRH3—obesity	0.000149	0.0542	CrCbGaD
Loxapine—DRD2—pituitary gland—obesity	0.000148	0.00465	CbGeAlD
Loxapine—ADRB1—endocrine gland—obesity	0.000148	0.00465	CbGeAlD
Loxapine—Mediastinal disorder—Orlistat—obesity	0.000147	0.00198	CcSEcCtD
Loxapine—HTR7—digestive system—obesity	0.000147	0.00461	CbGeAlD
Loxapine—HTR1A—adrenal gland—obesity	0.000146	0.0046	CbGeAlD
Loxapine—Dizziness—Diethylpropion—obesity	0.000146	0.00197	CcSEcCtD
Loxapine—SLC6A2—adrenal gland—obesity	0.000145	0.00456	CbGeAlD
Loxapine—Alopecia—Orlistat—obesity	0.000144	0.00194	CcSEcCtD
Loxapine—HTR2A—respiratory system—obesity	0.000144	0.00452	CbGeAlD
Loxapine—ADRA2C—pituitary gland—obesity	0.000144	0.00452	CbGeAlD
Loxapine—Angiopathy—Sibutramine—obesity	0.000143	0.00193	CcSEcCtD
Loxapine—ADRA2C—adipose tissue—obesity	0.000143	0.0045	CbGeAlD
Loxapine—SLC6A4—endocrine gland—obesity	0.000143	0.00449	CbGeAlD
Loxapine—CHRM1—endocrine gland—obesity	0.000142	0.00447	CbGeAlD
Loxapine—Vomiting—Diethylpropion—obesity	0.00014	0.00189	CcSEcCtD
Loxapine—HTR7—adrenal gland—obesity	0.00014	0.0044	CbGeAlD
Loxapine—Alopecia—Sibutramine—obesity	0.00014	0.00188	CcSEcCtD
Loxapine—Nasal congestion—Topiramate—obesity	0.000139	0.00188	CcSEcCtD
Loxapine—Rash—Diethylpropion—obesity	0.000139	0.00187	CcSEcCtD
Loxapine—Dysgeusia—Orlistat—obesity	0.000139	0.00187	CcSEcCtD
Loxapine—Dermatitis—Diethylpropion—obesity	0.000139	0.00187	CcSEcCtD
Loxapine—Dizziness—Cimetidine—obesity	0.000139	0.00187	CcSEcCtD
Loxapine—Headache—Diethylpropion—obesity	0.000138	0.00186	CcSEcCtD
Loxapine—Hepatitis—Bupropion—obesity	0.000138	0.00185	CcSEcCtD
Loxapine—Hypoaesthesia—Bupropion—obesity	0.000137	0.00185	CcSEcCtD
Loxapine—Muscle spasms—Orlistat—obesity	0.000137	0.00184	CcSEcCtD
Loxapine—Tension—Sibutramine—obesity	0.000135	0.00182	CcSEcCtD
Loxapine—ADRA1A—adrenal gland—obesity	0.000135	0.00424	CbGeAlD
Loxapine—Dysgeusia—Sibutramine—obesity	0.000135	0.00181	CcSEcCtD
Loxapine—Vision blurred—Orlistat—obesity	0.000134	0.0018	CcSEcCtD
Loxapine—Vomiting—Cimetidine—obesity	0.000134	0.0018	CcSEcCtD
Loxapine—Rash—Cimetidine—obesity	0.000133	0.00178	CcSEcCtD
Loxapine—Dermatitis—Cimetidine—obesity	0.000132	0.00178	CcSEcCtD
Loxapine—Muscle spasms—Sibutramine—obesity	0.000132	0.00178	CcSEcCtD
Loxapine—Headache—Cimetidine—obesity	0.000132	0.00177	CcSEcCtD
Loxapine—Nausea—Diethylpropion—obesity	0.000131	0.00177	CcSEcCtD
Loxapine—Vision blurred—Sibutramine—obesity	0.00013	0.00175	CcSEcCtD
Loxapine—Tremor—Sibutramine—obesity	0.000129	0.00174	CcSEcCtD
Loxapine—ADRA2C—adrenal gland—obesity	0.000128	0.00404	CbGeAlD
Loxapine—CHRM3—endocrine gland—obesity	0.000127	0.004	CbGeAlD
Loxapine—HTR1A—endocrine gland—obesity	0.000127	0.00399	CbGeAlD
Loxapine—Agitation—Sibutramine—obesity	0.000126	0.0017	CcSEcCtD
Loxapine—SLC6A2—endocrine gland—obesity	0.000126	0.00395	CbGeAlD
Loxapine—Angiopathy—Bupropion—obesity	0.000125	0.00168	CcSEcCtD
Loxapine—Nausea—Cimetidine—obesity	0.000125	0.00168	CcSEcCtD
Loxapine—Mediastinal disorder—Bupropion—obesity	0.000124	0.00167	CcSEcCtD
Loxapine—Cough—Orlistat—obesity	0.000124	0.00167	CcSEcCtD
Loxapine—Psychotic disorder—Topiramate—obesity	0.000124	0.00167	CcSEcCtD
Loxapine—Syncope—Sibutramine—obesity	0.000123	0.00166	CcSEcCtD
Loxapine—Convulsion—Orlistat—obesity	0.000123	0.00166	CcSEcCtD
Loxapine—Leukopenia—Sibutramine—obesity	0.000123	0.00166	CcSEcCtD
Loxapine—Alopecia—Bupropion—obesity	0.000122	0.00164	CcSEcCtD
Loxapine—HTR7—endocrine gland—obesity	0.000121	0.00381	CbGeAlD
Loxapine—Chest pain—Orlistat—obesity	0.000121	0.00163	CcSEcCtD
Loxapine—Loss of consciousness—Sibutramine—obesity	0.000121	0.00163	CcSEcCtD
Loxapine—Urinary retention—Topiramate—obesity	0.000121	0.00162	CcSEcCtD
Loxapine—Cough—Sibutramine—obesity	0.00012	0.00162	CcSEcCtD
Loxapine—Convulsion—Sibutramine—obesity	0.000119	0.0016	CcSEcCtD
Loxapine—Hypertension—Sibutramine—obesity	0.000119	0.0016	CcSEcCtD
Loxapine—Dry mouth—Orlistat—obesity	0.000118	0.00159	CcSEcCtD
Loxapine—Tension—Bupropion—obesity	0.000118	0.00158	CcSEcCtD
Loxapine—Dysgeusia—Bupropion—obesity	0.000117	0.00158	CcSEcCtD
Loxapine—Chest pain—Sibutramine—obesity	0.000117	0.00158	CcSEcCtD
Loxapine—ADRA1A—endocrine gland—obesity	0.000117	0.00368	CbGeAlD
Loxapine—HRH1—adipose tissue—obesity	0.000116	0.00366	CbGeAlD
Loxapine—Oedema—Orlistat—obesity	0.000116	0.00156	CcSEcCtD
Loxapine—Orthostatic hypotension—Topiramate—obesity	0.000116	0.00156	CcSEcCtD
Loxapine—Muscle spasms—Bupropion—obesity	0.000115	0.00155	CcSEcCtD
Loxapine—ADRA2A—pituitary gland—obesity	0.000115	0.00361	CbGeAlD
Loxapine—Dry mouth—Sibutramine—obesity	0.000115	0.00154	CcSEcCtD
Loxapine—DRD2—endocrine gland—obesity	0.000115	0.0036	CbGeAlD
Loxapine—ADRA2A—adipose tissue—obesity	0.000114	0.00359	CbGeAlD
Loxapine—Asenapine—DRD4—obesity	0.000114	0.0414	CrCbGaD
Loxapine—Nervous system disorder—Orlistat—obesity	0.000114	0.00153	CcSEcCtD
Loxapine—Confusional state—Sibutramine—obesity	0.000113	0.00152	CcSEcCtD
Loxapine—Vision blurred—Bupropion—obesity	0.000113	0.00152	CcSEcCtD
Loxapine—Tremor—Bupropion—obesity	0.000112	0.00151	CcSEcCtD
Loxapine—Oedema—Sibutramine—obesity	0.000112	0.00151	CcSEcCtD
Loxapine—Shock—Sibutramine—obesity	0.00011	0.00149	CcSEcCtD
Loxapine—Agitation—Bupropion—obesity	0.00011	0.00148	CcSEcCtD
Loxapine—HTR2A—cardiovascular system—obesity	0.00011	0.00346	CbGeAlD
Loxapine—Thrombocytopenia—Sibutramine—obesity	0.00011	0.00148	CcSEcCtD
Loxapine—Dysphagia—Topiramate—obesity	0.00011	0.00148	CcSEcCtD
Loxapine—Tachycardia—Sibutramine—obesity	0.00011	0.00148	CcSEcCtD
Loxapine—HRH1—digestive system—obesity	0.000109	0.00344	CbGeAlD
Loxapine—HTR7—liver—obesity	0.000109	0.00344	CbGeAlD
Loxapine—Syncope—Bupropion—obesity	0.000108	0.00145	CcSEcCtD
Loxapine—Leukopenia—Bupropion—obesity	0.000107	0.00145	CcSEcCtD
Loxapine—Loss of consciousness—Bupropion—obesity	0.000105	0.00142	CcSEcCtD
Loxapine—ADRA1A—liver—obesity	0.000105	0.00331	CbGeAlD
Loxapine—Insomnia—Orlistat—obesity	0.000105	0.00141	CcSEcCtD
Loxapine—Hypotension—Sibutramine—obesity	0.000105	0.00141	CcSEcCtD
Loxapine—Cough—Bupropion—obesity	0.000105	0.00141	CcSEcCtD
Loxapine—HRH1—adrenal gland—obesity	0.000104	0.00328	CbGeAlD
Loxapine—Paraesthesia—Orlistat—obesity	0.000104	0.0014	CcSEcCtD
Loxapine—Convulsion—Bupropion—obesity	0.000104	0.0014	CcSEcCtD
Loxapine—Hypertension—Bupropion—obesity	0.000104	0.00139	CcSEcCtD
Loxapine—ADRA2A—adrenal gland—obesity	0.000102	0.00322	CbGeAlD
Loxapine—Chest pain—Bupropion—obesity	0.000102	0.00137	CcSEcCtD
Loxapine—Insomnia—Sibutramine—obesity	0.000102	0.00137	CcSEcCtD
Loxapine—Asenapine—HTR1B—obesity	0.000101	0.0368	CrCbGaD
Loxapine—Paraesthesia—Sibutramine—obesity	0.000101	0.00136	CcSEcCtD
Loxapine—ADRA2C—liver—obesity	0.0001	0.00316	CbGeAlD
Loxapine—Gastrointestinal disorder—Orlistat—obesity	0.0001	0.00135	CcSEcCtD
Loxapine—Dyspnoea—Sibutramine—obesity	0.0001	0.00135	CcSEcCtD
Loxapine—Photosensitivity reaction—Topiramate—obesity	0.0001	0.00135	CcSEcCtD
Loxapine—Fatigue—Orlistat—obesity	0.0001	0.00135	CcSEcCtD
Loxapine—Dry mouth—Bupropion—obesity	9.99e-05	0.00134	CcSEcCtD
Loxapine—Somnolence—Sibutramine—obesity	9.98e-05	0.00134	CcSEcCtD
Loxapine—Weight increased—Topiramate—obesity	9.98e-05	0.00134	CcSEcCtD
Loxapine—Weight decreased—Topiramate—obesity	9.92e-05	0.00134	CcSEcCtD
Loxapine—Confusional state—Bupropion—obesity	9.87e-05	0.00133	CcSEcCtD
Loxapine—Oedema—Bupropion—obesity	9.79e-05	0.00132	CcSEcCtD
Loxapine—HTR2A—pituitary gland—obesity	9.75e-05	0.00307	CbGeAlD
Loxapine—Gastrointestinal disorder—Sibutramine—obesity	9.69e-05	0.0013	CcSEcCtD
Loxapine—Asenapine—DRD1—obesity	9.64e-05	0.0351	CrCbGaD
Loxapine—Shock—Bupropion—obesity	9.63e-05	0.0013	CcSEcCtD
Loxapine—Renal failure—Topiramate—obesity	9.61e-05	0.00129	CcSEcCtD
Loxapine—Constipation—Sibutramine—obesity	9.6e-05	0.00129	CcSEcCtD
Loxapine—Nervous system disorder—Bupropion—obesity	9.6e-05	0.00129	CcSEcCtD
Loxapine—Thrombocytopenia—Bupropion—obesity	9.58e-05	0.00129	CcSEcCtD
Loxapine—Feeling abnormal—Orlistat—obesity	9.56e-05	0.00129	CcSEcCtD
Loxapine—Tachycardia—Bupropion—obesity	9.55e-05	0.00129	CcSEcCtD
Loxapine—Feeling abnormal—Sibutramine—obesity	9.25e-05	0.00125	CcSEcCtD
Loxapine—Hypotension—Bupropion—obesity	9.15e-05	0.00123	CcSEcCtD
Loxapine—HTR2A—digestive system—obesity	9.14e-05	0.00288	CbGeAlD
Loxapine—Agranulocytosis—Topiramate—obesity	9.13e-05	0.00123	CcSEcCtD
Loxapine—HRH1—endocrine gland—obesity	9.05e-05	0.00285	CbGeAlD
Loxapine—Asenapine—ADRB1—obesity	8.94e-05	0.0325	CrCbGaD
Loxapine—ADRA2A—endocrine gland—obesity	8.89e-05	0.0028	CbGeAlD
Loxapine—Insomnia—Bupropion—obesity	8.85e-05	0.00119	CcSEcCtD
Loxapine—Paraesthesia—Bupropion—obesity	8.79e-05	0.00118	CcSEcCtD
Loxapine—Hepatitis—Topiramate—obesity	8.78e-05	0.00118	CcSEcCtD
Loxapine—Hypoaesthesia—Topiramate—obesity	8.73e-05	0.00118	CcSEcCtD
Loxapine—Dyspnoea—Bupropion—obesity	8.73e-05	0.00117	CcSEcCtD
Loxapine—HTR2A—adrenal gland—obesity	8.71e-05	0.00274	CbGeAlD
Loxapine—Somnolence—Bupropion—obesity	8.7e-05	0.00117	CcSEcCtD
Loxapine—Hypersensitivity—Orlistat—obesity	8.55e-05	0.00115	CcSEcCtD
Loxapine—Temazepam—GABRA6—obesity	8.54e-05	0.0311	CrCbGaD
Loxapine—Gastrointestinal disorder—Bupropion—obesity	8.45e-05	0.00114	CcSEcCtD
Loxapine—Fatigue—Bupropion—obesity	8.44e-05	0.00114	CcSEcCtD
Loxapine—Constipation—Bupropion—obesity	8.37e-05	0.00113	CcSEcCtD
Loxapine—Asthenia—Orlistat—obesity	8.32e-05	0.00112	CcSEcCtD
Loxapine—Hypersensitivity—Sibutramine—obesity	8.27e-05	0.00111	CcSEcCtD
Loxapine—Asenapine—HTR2C—obesity	8.24e-05	0.03	CrCbGaD
Loxapine—Pruritus—Orlistat—obesity	8.21e-05	0.00111	CcSEcCtD
Loxapine—Feeling abnormal—Bupropion—obesity	8.07e-05	0.00109	CcSEcCtD
Loxapine—Asthenia—Sibutramine—obesity	8.06e-05	0.00108	CcSEcCtD
Loxapine—Angiopathy—Topiramate—obesity	7.96e-05	0.00107	CcSEcCtD
Loxapine—Pruritus—Sibutramine—obesity	7.94e-05	0.00107	CcSEcCtD
Loxapine—Mediastinal disorder—Topiramate—obesity	7.91e-05	0.00107	CcSEcCtD
Loxapine—Alopecia—Topiramate—obesity	7.76e-05	0.00104	CcSEcCtD
Loxapine—Dizziness—Orlistat—obesity	7.67e-05	0.00103	CcSEcCtD
Loxapine—HTR2A—endocrine gland—obesity	7.55e-05	0.00238	CbGeAlD
Loxapine—Asenapine—ADRB2—obesity	7.52e-05	0.0274	CrCbGaD
Loxapine—Tension—Topiramate—obesity	7.5e-05	0.00101	CcSEcCtD
Loxapine—Dysgeusia—Topiramate—obesity	7.48e-05	0.00101	CcSEcCtD
Loxapine—Dizziness—Sibutramine—obesity	7.43e-05	0.001	CcSEcCtD
Loxapine—Vomiting—Orlistat—obesity	7.38e-05	0.000993	CcSEcCtD
Loxapine—Muscle spasms—Topiramate—obesity	7.35e-05	0.000989	CcSEcCtD
Loxapine—Rash—Orlistat—obesity	7.32e-05	0.000985	CcSEcCtD
Loxapine—Dermatitis—Orlistat—obesity	7.31e-05	0.000984	CcSEcCtD
Loxapine—Headache—Orlistat—obesity	7.27e-05	0.000978	CcSEcCtD
Loxapine—Hypersensitivity—Bupropion—obesity	7.21e-05	0.000971	CcSEcCtD
Loxapine—Vision blurred—Topiramate—obesity	7.2e-05	0.000969	CcSEcCtD
Loxapine—Tremor—Topiramate—obesity	7.16e-05	0.000964	CcSEcCtD
Loxapine—Vomiting—Sibutramine—obesity	7.14e-05	0.000961	CcSEcCtD
Loxapine—Rash—Sibutramine—obesity	7.08e-05	0.000953	CcSEcCtD
Loxapine—Dermatitis—Sibutramine—obesity	7.07e-05	0.000952	CcSEcCtD
Loxapine—Headache—Sibutramine—obesity	7.03e-05	0.000947	CcSEcCtD
Loxapine—Asthenia—Bupropion—obesity	7.02e-05	0.000945	CcSEcCtD
Loxapine—Agitation—Topiramate—obesity	7.02e-05	0.000945	CcSEcCtD
Loxapine—Pruritus—Bupropion—obesity	6.93e-05	0.000932	CcSEcCtD
Loxapine—Nausea—Orlistat—obesity	6.89e-05	0.000928	CcSEcCtD
Loxapine—Syncope—Topiramate—obesity	6.85e-05	0.000923	CcSEcCtD
Loxapine—Leukopenia—Topiramate—obesity	6.84e-05	0.000921	CcSEcCtD
Loxapine—Asenapine—SLC6A4—obesity	6.83e-05	0.0248	CrCbGaD
Loxapine—HTR2A—liver—obesity	6.81e-05	0.00214	CbGeAlD
Loxapine—Asenapine—DRD2—obesity	6.79e-05	0.0247	CrCbGaD
Loxapine—Loss of consciousness—Topiramate—obesity	6.72e-05	0.000904	CcSEcCtD
Loxapine—Clozapine—HRH3—obesity	6.68e-05	0.0243	CrCbGaD
Loxapine—Nausea—Sibutramine—obesity	6.67e-05	0.000898	CcSEcCtD
Loxapine—Cough—Topiramate—obesity	6.67e-05	0.000898	CcSEcCtD
Loxapine—Convulsion—Topiramate—obesity	6.62e-05	0.000891	CcSEcCtD
Loxapine—Hypertension—Topiramate—obesity	6.6e-05	0.000888	CcSEcCtD
Loxapine—Chest pain—Topiramate—obesity	6.51e-05	0.000876	CcSEcCtD
Loxapine—Dizziness—Bupropion—obesity	6.47e-05	0.000871	CcSEcCtD
Loxapine—Dry mouth—Topiramate—obesity	6.36e-05	0.000857	CcSEcCtD
Loxapine—Olanzapine—DRD4—obesity	6.33e-05	0.023	CrCbGaD
Loxapine—Confusional state—Topiramate—obesity	6.29e-05	0.000847	CcSEcCtD
Loxapine—Oedema—Topiramate—obesity	6.24e-05	0.00084	CcSEcCtD
Loxapine—Vomiting—Bupropion—obesity	6.22e-05	0.000838	CcSEcCtD
Loxapine—Rash—Bupropion—obesity	6.17e-05	0.000831	CcSEcCtD
Loxapine—Dermatitis—Bupropion—obesity	6.17e-05	0.00083	CcSEcCtD
Loxapine—Shock—Topiramate—obesity	6.14e-05	0.000826	CcSEcCtD
Loxapine—Headache—Bupropion—obesity	6.13e-05	0.000826	CcSEcCtD
Loxapine—Nervous system disorder—Topiramate—obesity	6.12e-05	0.000823	CcSEcCtD
Loxapine—Thrombocytopenia—Topiramate—obesity	6.11e-05	0.000822	CcSEcCtD
Loxapine—Tachycardia—Topiramate—obesity	6.09e-05	0.000819	CcSEcCtD
Loxapine—Thiothixene—SLC22A1—obesity	5.94e-05	0.0216	CrCbGaD
Loxapine—Hypotension—Topiramate—obesity	5.83e-05	0.000785	CcSEcCtD
Loxapine—Nausea—Bupropion—obesity	5.81e-05	0.000783	CcSEcCtD
Loxapine—Insomnia—Topiramate—obesity	5.64e-05	0.000759	CcSEcCtD
Loxapine—Zuclopenthixol—DRD1—obesity	5.63e-05	0.0205	CrCbGaD
Loxapine—Olanzapine—HTR1B—obesity	5.62e-05	0.0205	CrCbGaD
Loxapine—Paraesthesia—Topiramate—obesity	5.6e-05	0.000754	CcSEcCtD
Loxapine—Dyspnoea—Topiramate—obesity	5.56e-05	0.000748	CcSEcCtD
Loxapine—Somnolence—Topiramate—obesity	5.54e-05	0.000746	CcSEcCtD
Loxapine—Gastrointestinal disorder—Topiramate—obesity	5.38e-05	0.000725	CcSEcCtD
Loxapine—Fatigue—Topiramate—obesity	5.38e-05	0.000724	CcSEcCtD
Loxapine—Olanzapine—DRD1—obesity	5.36e-05	0.0195	CrCbGaD
Loxapine—Constipation—Topiramate—obesity	5.33e-05	0.000718	CcSEcCtD
Loxapine—Asenapine—HTR2A—obesity	5.25e-05	0.0191	CrCbGaD
Loxapine—Feeling abnormal—Topiramate—obesity	5.14e-05	0.000692	CcSEcCtD
Loxapine—Amoxapine—DRD4—obesity	5.04e-05	0.0183	CrCbGaD
Loxapine—Thiothixene—DRD1—obesity	4.85e-05	0.0177	CrCbGaD
Loxapine—Cyproheptadine—HTR2C—obesity	4.73e-05	0.0172	CrCbGaD
Loxapine—Hypersensitivity—Topiramate—obesity	4.59e-05	0.000619	CcSEcCtD
Loxapine—Olanzapine—HTR2C—obesity	4.59e-05	0.0167	CrCbGaD
Loxapine—Amoxapine—HTR1B—obesity	4.48e-05	0.0163	CrCbGaD
Loxapine—Asthenia—Topiramate—obesity	4.47e-05	0.000602	CcSEcCtD
Loxapine—Trazodone—HTR2C—obesity	4.43e-05	0.0161	CrCbGaD
Loxapine—Pruritus—Topiramate—obesity	4.41e-05	0.000594	CcSEcCtD
Loxapine—Amoxapine—DRD1—obesity	4.27e-05	0.0155	CrCbGaD
Loxapine—Azelastine—CYP2E1—obesity	4.23e-05	0.0154	CrCbGaD
Loxapine—Thiothixene—HTR2C—obesity	4.15e-05	0.0151	CrCbGaD
Loxapine—Dizziness—Topiramate—obesity	4.12e-05	0.000555	CcSEcCtD
Loxapine—Zuclopenthixol—DRD2—obesity	3.97e-05	0.0144	CrCbGaD
Loxapine—Prochlorperazine—HTR2C—obesity	3.97e-05	0.0144	CrCbGaD
Loxapine—Vomiting—Topiramate—obesity	3.97e-05	0.000534	CcSEcCtD
Loxapine—Rash—Topiramate—obesity	3.93e-05	0.000529	CcSEcCtD
Loxapine—Dermatitis—Topiramate—obesity	3.93e-05	0.000529	CcSEcCtD
Loxapine—Headache—Topiramate—obesity	3.91e-05	0.000526	CcSEcCtD
Loxapine—Cyproheptadine—DRD2—obesity	3.9e-05	0.0142	CrCbGaD
Loxapine—Quetiapine—DRD4—obesity	3.84e-05	0.014	CrCbGaD
Loxapine—Olanzapine—DRD2—obesity	3.78e-05	0.0137	CrCbGaD
Loxapine—Nausea—Topiramate—obesity	3.7e-05	0.000499	CcSEcCtD
Loxapine—Trazodone—SLC6A4—obesity	3.67e-05	0.0134	CrCbGaD
Loxapine—Amoxapine—HTR2C—obesity	3.65e-05	0.0133	CrCbGaD
Loxapine—Thiothixene—DRD2—obesity	3.42e-05	0.0124	CrCbGaD
Loxapine—Quetiapine—HTR1B—obesity	3.41e-05	0.0124	CrCbGaD
Loxapine—Clozapine—DRD4—obesity	3.31e-05	0.012	CrCbGaD
Loxapine—Prochlorperazine—DRD2—obesity	3.27e-05	0.0119	CrCbGaD
Loxapine—Quetiapine—DRD1—obesity	3.25e-05	0.0118	CrCbGaD
Loxapine—Zuclopenthixol—HTR2A—obesity	3.07e-05	0.0112	CrCbGaD
Loxapine—Amoxapine—SLC6A4—obesity	3.02e-05	0.011	CrCbGaD
Loxapine—Cyproheptadine—HTR2A—obesity	3.02e-05	0.011	CrCbGaD
Loxapine—Amoxapine—DRD2—obesity	3.01e-05	0.0109	CrCbGaD
Loxapine—Clozapine—HTR1B—obesity	2.94e-05	0.0107	CrCbGaD
Loxapine—Olanzapine—HTR2A—obesity	2.92e-05	0.0106	CrCbGaD
Loxapine—Trifluoperazine—HTR2C—obesity	2.87e-05	0.0104	CrCbGaD
Loxapine—Trazodone—HTR2A—obesity	2.82e-05	0.0103	CrCbGaD
Loxapine—Clozapine—DRD1—obesity	2.8e-05	0.0102	CrCbGaD
Loxapine—Quetiapine—HTR2C—obesity	2.78e-05	0.0101	CrCbGaD
Loxapine—Thiothixene—HTR2A—obesity	2.64e-05	0.00962	CrCbGaD
Loxapine—Clozapine—HTR2C—obesity	2.39e-05	0.00871	CrCbGaD
Loxapine—Trifluoperazine—DRD2—obesity	2.36e-05	0.0086	CrCbGaD
Loxapine—Amoxapine—HTR2A—obesity	2.32e-05	0.00846	CrCbGaD
Loxapine—Quetiapine—DRD2—obesity	2.29e-05	0.00834	CrCbGaD
Loxapine—Olanzapine—ALB—obesity	2e-05	0.00727	CrCbGaD
Loxapine—Clozapine—DRD2—obesity	1.97e-05	0.00718	CrCbGaD
Loxapine—Diazepam—CYP2E1—obesity	1.92e-05	0.00699	CrCbGaD
Loxapine—Clozapine—CYP2E1—obesity	1.9e-05	0.00691	CrCbGaD
Loxapine—Trifluoperazine—HTR2A—obesity	1.83e-05	0.00665	CrCbGaD
Loxapine—Thiothixene—ALB—obesity	1.81e-05	0.00658	CrCbGaD
Loxapine—Quetiapine—HTR2A—obesity	1.77e-05	0.00645	CrCbGaD
Loxapine—Clozapine—HTR2A—obesity	1.52e-05	0.00554	CrCbGaD
Loxapine—Diazepam—ALB—obesity	1.06e-05	0.00384	CrCbGaD
Loxapine—HTR1B—Signaling Pathways—TGFB1—obesity	4.65e-07	4.75e-06	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PIK3CB—obesity	4.65e-07	4.75e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IGF1—obesity	4.65e-07	4.74e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—AKT2—obesity	4.64e-07	4.74e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—RHOA—obesity	4.64e-07	4.74e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TYK2—obesity	4.63e-07	4.73e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—PIK3R1—obesity	4.63e-07	4.73e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NOS3—obesity	4.63e-07	4.73e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—PIK3R1—obesity	4.62e-07	4.72e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NOS3—obesity	4.62e-07	4.72e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TYK2—obesity	4.62e-07	4.72e-06	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PTGS2—obesity	4.61e-07	4.7e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—PIK3R1—obesity	4.61e-07	4.7e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NOS3—obesity	4.61e-07	4.7e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—RHOA—obesity	4.59e-07	4.69e-06	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—AKT1—obesity	4.59e-07	4.69e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—PIK3R1—obesity	4.59e-07	4.69e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NOS3—obesity	4.59e-07	4.69e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MYC—obesity	4.59e-07	4.69e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—RHOA—obesity	4.58e-07	4.68e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TGFB1—obesity	4.58e-07	4.67e-06	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—AKT1—obesity	4.57e-07	4.66e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—PIK3R1—obesity	4.55e-07	4.64e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NOS3—obesity	4.55e-07	4.64e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—PIK3R1—obesity	4.53e-07	4.63e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NOS3—obesity	4.53e-07	4.63e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MYC—obesity	4.53e-07	4.62e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—IL6—obesity	4.52e-07	4.62e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TGFB1—obesity	4.52e-07	4.61e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—IL6—obesity	4.5e-07	4.59e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MMP9—obesity	4.5e-07	4.59e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—PIK3CA—obesity	4.48e-07	4.58e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—PIK3CD—obesity	4.46e-07	4.55e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MMP9—obesity	4.45e-07	4.55e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—STAT3—obesity	4.45e-07	4.54e-06	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—AKT1—obesity	4.44e-07	4.54e-06	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	4.42e-07	4.51e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—SERPINE1—obesity	4.41e-07	4.5e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—PIK3CA—obesity	4.41e-07	4.5e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—PIK3CA—obesity	4.4e-07	4.49e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—STAT3—obesity	4.39e-07	4.48e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—PIK3CA—obesity	4.39e-07	4.48e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—IL6—obesity	4.37e-07	4.47e-06	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—AKT1—obesity	4.37e-07	4.47e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—PIK3CA—obesity	4.37e-07	4.46e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MAPK8—obesity	4.37e-07	4.46e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—AKT1—obesity	4.36e-07	4.45e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—PIK3CB—obesity	4.34e-07	4.43e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MTOR—obesity	4.34e-07	4.43e-06	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—AKT1—obesity	4.34e-07	4.43e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MYC—obesity	4.34e-07	4.43e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MAPK8—obesity	4.33e-07	4.42e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—PIK3CA—obesity	4.33e-07	4.42e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TGFB1—obesity	4.32e-07	4.42e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—AKT1—obesity	4.32e-07	4.41e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—PIK3CA—obesity	4.32e-07	4.41e-06	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—AKT1—obesity	4.31e-07	4.4e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—IL6—obesity	4.3e-07	4.4e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MMP9—obesity	4.3e-07	4.39e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TYK2—obesity	4.29e-07	4.38e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MMP9—obesity	4.28e-07	4.37e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MTOR—obesity	4.27e-07	4.36e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—PIK3CB—obesity	4.27e-07	4.36e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MTOR—obesity	4.26e-07	4.35e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—PIK3CB—obesity	4.26e-07	4.35e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—RHOA—obesity	4.26e-07	4.35e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—PIK3CB—obesity	4.25e-07	4.34e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MTOR—obesity	4.25e-07	4.34e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—PIK3CB—obesity	4.24e-07	4.33e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MTOR—obesity	4.24e-07	4.33e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—PIK3R1—obesity	4.21e-07	4.3e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NOS3—obesity	4.21e-07	4.3e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—PIK3CB—obesity	4.2e-07	4.28e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MTOR—obesity	4.2e-07	4.28e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—PIK3CB—obesity	4.18e-07	4.27e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MTOR—obesity	4.18e-07	4.27e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MAPK8—obesity	4.18e-07	4.27e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—AKT1—obesity	4.17e-07	4.26e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MMP9—obesity	4.16e-07	4.25e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MAPK8—obesity	4.16e-07	4.25e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—AKT1—obesity	4.15e-07	4.24e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MYC—obesity	4.13e-07	4.22e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TGFB1—obesity	4.12e-07	4.21e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MMP9—obesity	4.09e-07	4.18e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MYC—obesity	4.08e-07	4.16e-06	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—PIK3CA—obesity	4.07e-07	4.16e-06	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—PIK3CA—obesity	4.07e-07	4.15e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TGFB1—obesity	4.07e-07	4.15e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MAPK8—obesity	4.05e-07	4.13e-06	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—PIK3CA—obesity	4.04e-07	4.13e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—AKT1—obesity	4.04e-07	4.12e-06	CbGpPWpGaD
Loxapine—DRD2—GPCR downstream signaling—AKT1—obesity	4.03e-07	4.12e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—PIK3CA—obesity	4.01e-07	4.1e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—STAT3—obesity	4e-07	4.08e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MAPK8—obesity	3.98e-07	4.07e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—AKT1—obesity	3.97e-07	4.05e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—IL6—obesity	3.97e-07	4.05e-06	CbGpPWpGaD
Loxapine—HTR2A—GPCR downstream signaling—AKT1—obesity	3.97e-07	4.05e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—STAT3—obesity	3.96e-07	4.04e-06	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—AKT1—obesity	3.96e-07	4.04e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—PIK3CA—obesity	3.96e-07	4.04e-06	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—AKT1—obesity	3.95e-07	4.03e-06	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—AKT1—obesity	3.93e-07	4.02e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—IL6—obesity	3.91e-07	3.99e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—IL6—obesity	3.9e-07	3.98e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—PIK3CA—obesity	3.9e-07	3.98e-06	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—AKT1—obesity	3.9e-07	3.98e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—PIK3CB—obesity	3.89e-07	3.97e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MTOR—obesity	3.89e-07	3.97e-06	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—AKT1—obesity	3.88e-07	3.97e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—IL6—obesity	3.88e-07	3.97e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—IL6—obesity	3.87e-07	3.95e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—PIK3CA—obesity	3.84e-07	3.92e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—IL6—obesity	3.83e-07	3.91e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—IL6—obesity	3.82e-07	3.9e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—STAT3—obesity	3.82e-07	3.9e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—STAT3—obesity	3.8e-07	3.88e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MMP9—obesity	3.78e-07	3.85e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MMP9—obesity	3.71e-07	3.79e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MYC—obesity	3.71e-07	3.79e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MMP9—obesity	3.71e-07	3.78e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TGFB1—obesity	3.7e-07	3.78e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—STAT3—obesity	3.7e-07	3.78e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MMP9—obesity	3.69e-07	3.77e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MMP9—obesity	3.68e-07	3.76e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—PIK3CA—obesity	3.68e-07	3.76e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MYC—obesity	3.68e-07	3.76e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MAPK8—obesity	3.67e-07	3.75e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TGFB1—obesity	3.67e-07	3.75e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—AKT1—obesity	3.66e-07	3.74e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MMP9—obesity	3.65e-07	3.72e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—STAT3—obesity	3.64e-07	3.72e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MMP9—obesity	3.64e-07	3.71e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MAPK8—obesity	3.61e-07	3.69e-06	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—AKT1—obesity	3.61e-07	3.69e-06	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—IL6—obesity	3.61e-07	3.68e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MAPK8—obesity	3.6e-07	3.68e-06	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—IL6—obesity	3.6e-07	3.68e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—AKT1—obesity	3.6e-07	3.68e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—AKT1—obesity	3.59e-07	3.67e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MAPK8—obesity	3.59e-07	3.67e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—AKT1—obesity	3.58e-07	3.66e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MAPK8—obesity	3.58e-07	3.66e-06	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—IL6—obesity	3.58e-07	3.66e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—AKT1—obesity	3.57e-07	3.65e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—IL6—obesity	3.55e-07	3.63e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MYC—obesity	3.55e-07	3.63e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MAPK8—obesity	3.55e-07	3.62e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TGFB1—obesity	3.54e-07	3.62e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—AKT1—obesity	3.54e-07	3.61e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MAPK8—obesity	3.54e-07	3.61e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MYC—obesity	3.53e-07	3.61e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—AKT1—obesity	3.53e-07	3.6e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TGFB1—obesity	3.53e-07	3.6e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—PIK3CA—obesity	3.51e-07	3.58e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—IL6—obesity	3.51e-07	3.58e-06	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—PIK3CA—obesity	3.49e-07	3.56e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—PIK3CA—obesity	3.46e-07	3.53e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—IL6—obesity	3.45e-07	3.52e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MYC—obesity	3.44e-07	3.51e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TGFB1—obesity	3.43e-07	3.5e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—IL6—obesity	3.4e-07	3.47e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MYC—obesity	3.38e-07	3.45e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MMP9—obesity	3.38e-07	3.45e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TGFB1—obesity	3.37e-07	3.45e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—STAT3—obesity	3.36e-07	3.43e-06	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—AKT1—obesity	3.33e-07	3.4e-06	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—AKT1—obesity	3.32e-07	3.39e-06	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—AKT1—obesity	3.3e-07	3.37e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—STAT3—obesity	3.3e-07	3.37e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—STAT3—obesity	3.3e-07	3.36e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MAPK8—obesity	3.29e-07	3.36e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—STAT3—obesity	3.29e-07	3.35e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—AKT1—obesity	3.28e-07	3.35e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—STAT3—obesity	3.27e-07	3.34e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—IL6—obesity	3.26e-07	3.33e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—STAT3—obesity	3.24e-07	3.31e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—AKT1—obesity	3.23e-07	3.3e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—STAT3—obesity	3.23e-07	3.3e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—AKT1—obesity	3.18e-07	3.25e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—PIK3CA—obesity	3.15e-07	3.22e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—AKT1—obesity	3.14e-07	3.21e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—PIK3CA—obesity	3.12e-07	3.19e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MYC—obesity	3.12e-07	3.18e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TGFB1—obesity	3.11e-07	3.18e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—IL6—obesity	3.11e-07	3.17e-06	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—PIK3CA—obesity	3.09e-07	3.15e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MYC—obesity	3.07e-07	3.13e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—IL6—obesity	3.06e-07	3.13e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MYC—obesity	3.06e-07	3.13e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TGFB1—obesity	3.06e-07	3.13e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TGFB1—obesity	3.05e-07	3.12e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MYC—obesity	3.05e-07	3.12e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TGFB1—obesity	3.05e-07	3.11e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MYC—obesity	3.04e-07	3.11e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TGFB1—obesity	3.04e-07	3.1e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—PIK3CA—obesity	3.02e-07	3.08e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MYC—obesity	3.01e-07	3.08e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—AKT1—obesity	3.01e-07	3.07e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TGFB1—obesity	3.01e-07	3.07e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MYC—obesity	3e-07	3.07e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—STAT3—obesity	3e-07	3.07e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—PIK3CA—obesity	3e-07	3.06e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TGFB1—obesity	3e-07	3.06e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—PIK3CA—obesity	2.92e-07	2.98e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—PIK3CA—obesity	2.87e-07	2.93e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—AKT1—obesity	2.86e-07	2.92e-06	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—AKT1—obesity	2.85e-07	2.91e-06	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PIK3CA—obesity	2.83e-07	2.89e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—AKT1—obesity	2.83e-07	2.89e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MYC—obesity	2.79e-07	2.85e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IL6—obesity	2.79e-07	2.85e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TGFB1—obesity	2.79e-07	2.84e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IL6—obesity	2.77e-07	2.82e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IL6—obesity	2.67e-07	2.73e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IL6—obesity	2.66e-07	2.71e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—PIK3CA—obesity	2.65e-07	2.7e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—PIK3CA—obesity	2.61e-07	2.66e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—PIK3CA—obesity	2.6e-07	2.65e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—PIK3CA—obesity	2.59e-07	2.65e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IL6—obesity	2.58e-07	2.64e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—PIK3CA—obesity	2.58e-07	2.64e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—AKT1—obesity	2.58e-07	2.63e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—PIK3CA—obesity	2.56e-07	2.61e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—AKT1—obesity	2.55e-07	2.61e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—PIK3CA—obesity	2.55e-07	2.6e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IL6—obesity	2.54e-07	2.6e-06	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—AKT1—obesity	2.52e-07	2.58e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—AKT1—obesity	2.46e-07	2.52e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—AKT1—obesity	2.45e-07	2.5e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—AKT1—obesity	2.38e-07	2.43e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—PIK3CA—obesity	2.37e-07	2.42e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—AKT1—obesity	2.35e-07	2.4e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IL6—obesity	2.34e-07	2.39e-06	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—AKT1—obesity	2.32e-07	2.36e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IL6—obesity	2.31e-07	2.36e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IL6—obesity	2.3e-07	2.35e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IL6—obesity	2.29e-07	2.34e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IL6—obesity	2.29e-07	2.34e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL6—obesity	2.27e-07	2.31e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL6—obesity	2.26e-07	2.31e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—AKT1—obesity	2.16e-07	2.21e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—AKT1—obesity	2.13e-07	2.17e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—AKT1—obesity	2.12e-07	2.17e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—AKT1—obesity	2.12e-07	2.16e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—AKT1—obesity	2.11e-07	2.15e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL6—obesity	2.1e-07	2.14e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—AKT1—obesity	2.09e-07	2.13e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—AKT1—obesity	2.08e-07	2.13e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—AKT1—obesity	1.94e-07	1.98e-06	CbGpPWpGaD
